Pharmaceuticals
Medical devices

Products

Oncology Injection Oncology Injection

Understanding chemico-physical status from API to formulation gives better performance than original drugs.

Name Active Ingredient / Formulation Strength Indication Characteristics
Genexol® PM Inj.
Genexol® PM Inj.
Paclitaxel/Lyo. 30mg,
100mg		 Breast cancer,
NSCLC,
Ovarian cancer
  • Cremophor-free
  • Higher MTD
  • No alcohol intoxication
Nanoxel® M Inj.
Nanoxel® M Inj.
Docetaxel/Lyo. 20mg,
80mg		 Breast cancer,
NSCLC,
Esophageal cancer,
Ovarian cancer,
H&N cancer,
Gastric cancer,
Prostate cancer
  • Polysorbate 80-free
  • No alcohol intoxication
Genexol® Inj.
Genexol® Inj.
Paclitaxel/Liq. 30mg,
100mg,
300mg 		Breast cancer,
NSCLC,
Ovarian cancer
  • Cremophor-containing formulation
Docetaxel Inj.
Docetaxel Inj.
Docetaxel/Liq. 20mg,
80mg,
140mg,
160mg 		Breast cancer,
NSCLC,
Esophageal cancer,
Ovarian cancer,
H&N cancer,
Gastric cancer,
Prostate cancer
  • 1-vial liq. Inj.
  • Ready to use
Zolenic® Inj.
Zolenic® Inj.
Zoledronic acid/Liq. 4mg Bone complications of cancer
  • Same efficacy with the Original product
Nexatin® Inj.
Nexatin® Inj.
Oxaliplatin/Liq. 50mg,
100mg,
200mg 		Colorectal cancer,
Gastric cancer
  • Same efficacy with the Original product
Pemed® Inj.
Pemed® Inj.
Pemetrexed/Lyo. & Liq. 100mg,
500mg,
1,000mg 		NSCLC
  • RTU & Lyo
  • Cold & Room
Crabcitabin® Inj.
Gemcitabine/Liq. 200mg,
1,000mg 		Pancreas, Lung, Ovary, and Breast
  • Cold storage
Protezomib® Inj.
Protezomib® Inj.
Bortezomib/Lyo. 3.5mg,
2.5mg 		Mantle cell lymphoma, Multiple Myeloma
  • Same efficacy with the Original product
Palonosetron Inj.
 Palonosetron/Liq 0.075mg,
0.25mg 		Antiemetics
  • 5-HT3 antagonist
  • No EDTA
  • No patent infringement
  • Same efficacy with the Original product
Emestop® Inj.
Ramosetron/Liq 0.3mg Antiemetics
  • Same efficacy with the Original product
Emestop® FDT
Ramosetron/Tablet 0.1mg Antiemetics
  • Same efficacy with the Original product
Lenalid® Tab
Lenalid® Tab
Lenalidomide/Tab 2.5mg,
5mg,
7.5mg,
10mg,
15mg,
20mg,
25mg 		Multiple Myeloma (MM),
Myelodysplastic Syndrome (MDS),
Mantle Cell Lymphoma (MCL)
  • Increased Patient Compliance
  • Completion of BE Studies
  • Guaranteed Safety of Drug Product
Lenalid® Tab
Azalid®
 Azacitidine/Lyo. 150mg Myelodysplastic syndrome(MDS),
Acute myeloid leukemia (AML),
Chronic bone mineral composition leukemia (CMML)
  • Same efficacy with the original product
Lenalid® Tab
Decilid®
 Decitabine/Lyo. 40mg Myelodysplastic syndrome(MDS),
Chronic bone mineral composition leukemia (CMML)
  • Same efficacy with the original product